Vaccines

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

New strains of the mumps virus are not to blame for the recent resurgence of cases, say researchers in a new study, instead pinning the recent outbreaks on declining protective effects of the mumps vaccine over time.

Representatives from Novavax, Inc., an American-based biotechnology company, presented data at the recent World Vaccine Congress in Washington, DC, on their vaccines under development for the flu and RSV.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

Investigators set out to find out why pertussis rates in the United States have been rising steadily despite the availability of a vaccine.

Health officials around the United States are still recommending the flu shot for late-season protection against the second wave of flu caused by influenza B.

Health officials are in the process of investigating a mumps outbreak that has sprung up among attendees of Mexican dance events in Delaware.

These recommendations come on the heels of a review of the vaccine by the WHO’s Strategic Advisory Group of Experts on Immunization in October 2017.

Marin H. Kollef, MD, discusses new therapies in development for the treatment of Pseudomonas infections.

In case you missed them, we've compiled the top 5 articles from this past week.

While a new study has found that the HPV vaccination rate has more than tripled among young men in the United States, rates for both males and females are still well below public health targets.

With influenza B making a late-season rise, health officials are warning that B viruses may cause a second wave of flu this season, while the FDA is backing some alternatives to egg-based flu vaccines.

As an outbreak of Lassa fever in Nigeria continues to spread, the Coalition for Epidemic Preparedness Innovations is working with Themis Bioscience to develop a vaccine to protect against the virus.

AIDS researcher Robert Redfield, MD, has officially been named the new director of the CDC.

The National Center for Health Statistics has released new data on flu vaccination rates in the United States, as 1 new study shows which airline passengers may be at greatest risk of catching the flu inflight.

Falsified hepatitis B vaccines were discovered at 8 health facilities in Uganda.

In the wake of news of 10 travelers being infected with yellow fever, 4 of whom have died, the Centers for Disease Control and Prevention (CDC) are urging anyone considering travel to yellow fever endemic regions of Brazil to be vaccinated prior to travel.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

The New Jersey Department of Health has issued a public health alert warning of another potential measles exposure at Newark International Airport.

At present, multiple vaccine candidates are in various stages of research and development, including cabotegravir, which is currently in phase 3 trials, and vaccines based on broadly-neutralizing antibodies.

As flu activity continues to decline in the United States, some states are still reporting a record number of flu illnesses, as a new study debunks concerns that the use of Tamiflu may lead to increased suicide risk in teens.

In the wake of Europe’s recent 4-fold increase in measles cases, countries such as Italy, Germany, and Romania are passing tougher laws requiring vaccinations for children being enrolled in school.

Flu activity is down for the second week in a row in the United States, but as the flu season still has several weeks to go, the FDA has issued a warning about counterfeit flu medications.

New research from Australia supports the use of booster doses of the pneumococcal conjugate vaccine, but it shows overall effectiveness is high.

Better understanding of the pathogenesis of tuberculosis can help inform the development of a new, effective vaccine.

The US Food and Drug Administration (FDA) has weighed in on the strains to be included in the 2018-2019 influenza vaccine.

The results of the trial revealed that the tablet reduced the rate of infection with influenza by 48%.

The institute has made the development of the vaccine “one of its highest priorities.”

A new bill introduced by a group of senators aims to boost universal flu vaccine research by $1 billion over the next 5 years, as health officials continue to investigate the cause of the flu shot’s low efficacy.